---
document_datetime: 2023-09-21 19:12:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ranexa-epar-all-authorised-presentations_en.pdf
document_name: ranexa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7944487
conversion_datetime: 2025-12-18 08:39:41.105859
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Numbers      | Invented name   | Strength   | Pharmaceutical Form      | Route of administration   | Packaging              | Package size   |
|-----------------|-----------------|------------|--------------------------|---------------------------|------------------------|----------------|
| EU/1/08/462/001 | Ranexa          | 375 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 60 tablets     |
| EU/1/08/462/002 | Ranexa          | 375 mg     | Prolonged release tablet | Oral use                  | Bottle (HDPE)          | 60 tablets     |
| EU/1/08/462/003 | Ranexa          | 500 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 60 tablets     |
| EU/1/08/462/004 | Ranexa          | 500 mg     | Prolonged release tablet | Oral use                  | Bottle (HDPE)          | 60 tablets     |
| EU/1/08/462/005 | Ranexa          | 750 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 60 tablets     |
| EU/1/08/462/006 | Ranexa          | 750 mg     | Prolonged release tablet | Oral use                  | Bottle (HDPE)          | 60 tablets     |
| EU/1/08/462/007 | Ranexa          | 375 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 30 tablets     |
| EU/1/08/462/008 | Ranexa          | 375 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 100 tablets    |
| EU/1/08/462/009 | Ranexa          | 500 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 30 tablets     |
| EU/1/08/462/010 | Ranexa          | 500 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 100 tablets    |
| EU/1/08/462/011 | Ranexa          | 750 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 30 tablets     |
| EU/1/08/462/012 | Ranexa          | 750 mg     | Prolonged release tablet | Oral use                  | Blister (PVC/PVDC/alu) | 100 tablets    |